CREATES Act Approaches Finish Line But Legislation May Fail To Launch

Broad bipartisan support and billions in projected savings mean that bill may finally pass. But whether it will work as intended to improve generic access to market remains as questionable as ever.  

Run to the finish line - Image

More from Generics

More from Biosimilars & Generics